Cumberland Pharmaceuticals (CPIX) Stock: Buy, Sell, or Hold?
$6.31
+1.01 (+19.06%)
▲
5d:
+42.12%
30d:
-11.99%
90d:
-20.13%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (94%)
Quality Score
54/100
Position
FAIR
30-Day Fair Range
$4.85 – $7.63
Position: FAIR
Forward P/E & Valuation
50.0x
Next 12M consensus est.
Wall Street Target
$8.50
+60.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.08 / $5.58
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: CPIX shows positive signals but monitor for confirmation. Moderate conviction.
Get Alerted When CPIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CPIX is currently trading at $6.31, which is considered fair relative to its 30-day fair value range of $4.85 to $7.63.
Technical Outlook: Technically, CPIX is showing sideways momentum. The price is approaching resistance at $5.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 19.1% recently.
Market Sentiment: CPIX scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.50 (+60.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CPIX is showing sideways momentum. The price is approaching resistance at $5.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 19.1% recently.
Market Sentiment: CPIX scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.50 (+60.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.85 -
$7.63
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
93.8%
Trading Range & Key Levels
30-Day Trading Range
$4.85 -
$7.63
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.97
(15.4%)
Support Level
$4.08
Resistance Level
$5.58
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+19.1%)
- BULLISH: Trading 60.4% below Wall St target ($8.50)
- BULLISH: Bottoming setup score 65/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
50.00
Wall Street Target
$8.50
(+60.4%)
Revenue Growth (YoY)
-56.3%
Profit Margin
-24.6%
Share CPIX Analysis
Share this live CPIX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CPIX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Cumberland Pharmaceuticals reported Q3 earnings of $77.8 million following the sale of its commercial products to Apotex Health. The company refocused its strategy on developing treatments for rare diseases and announced plans to evaluate commercialization opportunities for its drug candidates.
Key Retail Themes:
Strategic shift in focus
Financial position improvement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 1:57 PM ET
Data refreshes hourly during market hours. Next update: 2:57 PM
Data refreshes hourly during market hours. Next update: 2:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CPIX Research Pages
